Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT2 | P31751 | 15/20 | 0.46 |
| ▸ | AKT1 | P31749 | 14/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CGAS | Q8N884 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | FLT3 | P36888 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23959297 | 0.88 | AKT2 (0.48) | AKT2AKT1TP53GAAMAPT | |
| SCHEMBL23959294 | 0.86 | AKT2 (0.49) | AKT2AKT1FLT3 | |
| SCHEMBL23959119 | 0.85 | AKT1 (0.47) | AKT2AKT1 | |
| SCHEMBL23959278 | 0.84 | AKT1 (0.46) | AKT2AKT1TP53GAAMAPT | |
| SCHEMBL23959284 | 0.83 | AKT2 (0.50) | AKT2AKT1TP53GAAMAPT | |
| SCHEMBL23959214 | 0.79 | AKT1 (0.45) | AKT2AKT1MAPT | |
| SCHEMBL23959300 | 0.78 | AKT2 (0.45) | AKT2AKT1 | |
| SCHEMBL23959298 | 0.78 | AKT2 (0.51) | AKT2AKT1 | |
| SCHEMBL23959252 | 0.77 | AKT1 (0.43) | AKT2AKT1MAPT | |
| SCHEMBL17449605 | 0.76 | L3MBTL1 (0.42) | TP53MAPTSMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11192901-B2 | Nitrogen-containing heterocyclic organic compound and organic electroluminescent device | SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-12-07 | — | — | US | disclosed |
| US-20210332066-A1 | NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11192901-B2 | Nitrogen-containing heterocyclic organic compound and organic electroluminescent device | H1-10, H1-0, OR10J3 | AKT2 1711/4885AKT1 1176/4885TP53 4242/4885 |
| US-20210332066-A1 | NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | H1-10, H1-0, OR10J3 | AKT2 1711/4885AKT1 1176/4885TP53 4242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.